- Determining shape and size of binding sites
- Identifying mutations causing a change in binding site shape
- Aid in designing effective drugs to inhibit proteins e.g. designing Nevirapine to obstruct the polymerase active site within HIV-1 reverse transcriptase (integral in HIV)
- Identifying protein-ligand binding mechanisms and protein functions